Compression Stockings Therapy Following Mechano-Chemical Ablation (Clarivein®)

NCT03685838 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2020-10-30

No results posted yet for this study

Summary

This study will be looking at the effect of compression therapy in patients having Mechano-Chemical Ablation (MOCA) therapy for truncal incompetence of their varicose veins using the ClariVein® device. Patients will be randomised to either the compression group (group A) or the no compression group (group B).

The pain scores, compliance, quality of life scores, occlusion rate at 6 months as well as the cost effectiveness of each intervention will be assessed.

Conditions

  • Varicose Veins
  • Chronic Venous Insufficiency

Interventions

OTHER

Compression Stockings

Class II above knee compression stockings

Sponsors & Collaborators

  • National University of Ireland, Galway, Ireland

    collaborator OTHER
  • Singapore General Hospital

    lead OTHER

Principal Investigators

  • Tang Tjun Yip · Singapore General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-13
Primary Completion
2021-10-01
Completion
2022-10-01

Countries

  • Ireland
  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03685838 on ClinicalTrials.gov